AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 163 filers reported holding AGIOS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 1.81 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $331 | -99.8% | 73,798 | +32.0% | 0.01% | -18.2% |
| Q3 2022 | $169,000 | -37.9% | 55,899 | +847.6% | 0.01% | -26.7% |
| Q3 2021 | $272,000 | -16.3% | 5,899 | 0.0% | 0.02% | -16.7% |
| Q2 2021 | $325,000 | +6.6% | 5,899 | 0.0% | 0.02% | 0.0% |
| Q1 2021 | $305,000 | +19.1% | 5,899 | 0.0% | 0.02% | +12.5% |
| Q4 2020 | $256,000 | +24.3% | 5,899 | 0.0% | 0.02% | +6.7% |
| Q3 2020 | $206,000 | – | 5,899 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Ventures 2007 General Partner LLC | 1,930,369 | $118,428,000 | 83.56% |
| Third Rock Ventures, LLC | 3,070,090 | $188,350,000 | 21.97% |
| Opaleye Management Inc. | 113,500 | $6,963,225,000 | 5.43% |
| BB BIOTECH AG | 1,890,521 | $115,983,000 | 4.72% |
| Eventide Asset Management | 431,600 | $26,479,000 | 3.70% |
| Atika Capital Management LLC | 54,000 | $3,313,000 | 2.55% |
| Cormorant Asset Management, LP | 100,000 | $6,135,000 | 1.26% |
| BRIDGER MANAGEMENT, LLC | 220,099 | $13,503,000 | 0.92% |
| Ghost Tree Capital, LLC | 20,000 | $1,227,000 | 0.67% |
| HAMILTON LANE ADVISORS LLC | 27,544 | $1,690,000 | 0.55% |